Journal of Clinical Endocrinology & Metabolism, Vol 58, 223-230, Copyright © 1984 by Endocrine Society

ARTICLES

Age-related changes in parathyroid hormone and parathyroid hormone action in normal humans

R Marcus, P Madvig and G Young

We evaluated parathyroid function in 158 normal subjects, aged 23-85 yr. Calcium, phosphorus, creatinine, and cAMP were measured in blood and urine in the fasting state and after a 1-g oral calcium challenge. Serum immunoreactive PTH (iPTH) was measured with a goat antiserum developed against human PTH, using (43Tyr) human PTH-(44-68) as tracer and standards. With age, a decrease in total serum Ca (r = -0.14; P less than 0.05) was attributable to a fall in serum albumin (r = -0.40; P less than 0.001). Creatinine clearance fell from 124 ml/min at age 20 yr to 61 ml/min at age 80 yr (r = -0.44; P less than 0.001). iPTH rose with age in men (r = 0.21; P less than 0.05) and women (r = 0.31; P less than 0.001) from 29 pg/ml at age 20 yr to 48 pg/ml at 80 yr. iPTH was also correlated with creatinine clearance (r = -0.32; P less than 0.001. When renal function was controlled in the analysis, the regression of iPTH with age was no longer significant. Other significant correlations with age include a decrease in renal phosphorus reabsorption (r = -0.17; P less than 0.05) and an increase in urinary nephrogenous cAMP excretion (r = 0.34; P less than 0.01). The rise in nephrogenous cAMP was not accompanied by a change in total urinary cAMP, since plasma, and therefore filtered, cAMP decreased with age. Basal calcium excretion was stable, but the calciuric response to oral calcium decreased (r = -0.27; P less than 0.01). We conclude that loss of renal function is the major cause of rising iPTH levels with age.

This article has been cited by other articles:

				H. Blain, A. Vuillemin, A. Blain, F. Guillemin, N. D. Talance, B. Doucet, and C. Jeandel Age-Related Femoral Bone Loss in Men: Evidence for Hyperparathyroidism and Insulin-Like Growth Factor-1 Deficiency J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2004; 59(12): 1285 - 1289. [Abstract] [Full Text] [PDF]

				A. G. Need, P. D. O'Loughlin, H. A. Morris, M. Horowitz, and B. E. C. Nordin The Effects of Age and Other Variables on Serum Parathyroid Hormone in Postmenopausal Women Attending an Osteoporosis Center J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1646 - 1649. [Abstract] [Full Text] [PDF]

				J.-C. Souberbielle, E. Lawson-Body, B. Hammadi, E. Sarfati, A. Kahan, and C. Cormier The Use in Clinical Practice of Parathyroid Hormone Normative Values Established in Vitamin D-Sufficient Subjects J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3501 - 3504. [Abstract] [Full Text] [PDF]

				D. Rucker, J. A. Allan, G. H. Fick, and D. A. Hanley Vitamin D insufficiency in a population of healthy western Canadians Can. Med. Assoc. J., June 1, 2002; 166(12): 1517 - 1524. [Abstract] [Full Text] [PDF]

				P. Lips Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications Endocr. Rev., August 1, 2001; 22(4): 477 - 501. [Abstract] [Full Text] [PDF]

				S. Pattanaungkul, B. L. Riggs, A. L. Yergey, N. E. Vieira, W. M. O’Fallon, and S. Khosla Relationship of Intestinal Calcium Absorption to 1,25-Dihydroxyvitamin D [1,25(OH)2D] Levels in Young Versus Elderly Women: Evidence for Age-Related Intestinal Resistance to 1,25(OH)2D Action J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4023 - 4027. [Abstract] [Full Text]

				A. E. Hak, H. A. P. Pols, A. M. van Hemert, A. Hofman, and J. C. M. Witteman Progression of Aortic Calcification Is Associated With Metacarpal Bone Loss During Menopause : A Population-Based Longitudinal Study Arterioscler. Thromb. Vasc. Biol., August 1, 2000; 20(8): 1926 - 1931. [Abstract] [Full Text] [PDF]